Mucopolysaccharidosis I: management and treatment guidelines

Pediatrics
Joseph MuenzerInternational Consensus Panel on Management and Treatment of Mucopolysaccharidosis I

Abstract

Disease management for mucopolysaccharidosis type I has been inconsistent because of disease rarity (approximately 1 case per 100,000 live births), phenotypic heterogeneity, and limited therapeutic options. The availability of hematopoietic stem cell transplantation and the recent introduction of enzyme replacement therapy for mucopolysaccharidosis I necessitate the establishment of system-specific management guidelines for this condition. Twelve international experts on mucopolysaccharidosis I met in January 2003 to draft management and treatment guidelines for mucopolysaccharidosis I. Initial guidelines were revised and updated in 2008, on the basis of additional clinical data and therapeutic advances. Recommendations are based on our extensive clinical experience and a review of the literature. All patients with mucopolysaccharidosis I should receive a comprehensive baseline evaluation, including neurologic, ophthalmologic, auditory, cardiac, respiratory, gastrointestinal, and musculoskeletal assessments, and should be monitored every 6 to 12 months with individualized specialty assessments, to monitor disease progression and effects of intervention. Patients are best treated by a multidisciplinary team. Treatments consist o...Continue Reading

Citations

Nov 1, 2011·European Journal of Pediatrics·Joseph MuenzerPaul Harmatz
Jan 12, 2012·European Journal of Pediatrics·Kristin D'AcoPaige Kaplan
Mar 3, 2012·European Journal of Pediatrics·Barbara K Burton, Roberto Giugliani
Jun 30, 2009·Journal of Inherited Metabolic Disease·A NashedI Narang
Jun 10, 2010·Journal of Inherited Metabolic Disease·Janet A ThomasGerald F Cox
Jul 12, 2011·Journal of Inherited Metabolic Disease·Elizabeth A BraunlinRoberto Giugliani
Jul 10, 2012·Journal of Inherited Metabolic Disease·Louise D ArcherJames E Fildes
Nov 16, 2012·Journal of Inherited Metabolic Disease·Kenneth I BergerDavid M Rapoport
May 9, 2013·Journal of Inherited Metabolic Disease·Louise D ArcherJames E Fildes
Jul 3, 2013·Journal of Inherited Metabolic Disease·Kariman Abelin GenevoisRémi Kohler
Nov 10, 2009·Bone Marrow Transplantation·P J OrchardJ Tolar
Dec 12, 2012·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Beth K PotterUNKNOWN Canadian Inherited Metabolic Diseases Research Network
Jun 15, 2011·Human Gene Therapy·Mark J OsbornJakub Tolar
Jan 11, 2012·Rheumatology·Thomas J A LehmanJoan Keutzer
Jan 11, 2012·Rheumatology·Klane K White
Jan 11, 2012·Rheumatology·Joseph Muenzer
Jan 11, 2012·Rheumatology·Vassili Valayannopoulos, Frits A Wijburg
Jul 3, 2013·Journal of Pediatric Orthopedics·Dinesh P ThawraniPaul J Orchard
Apr 20, 2011·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Raymond Y WangUNKNOWN ACMG Work Group on Diagnostic Confirmation of Lysosomal Storage Diseases
Nov 30, 2011·International Ophthalmology Clinics·Robert J Courtney, Mark E Pennesi
Oct 27, 2009·Pediatric Rheumatology Online Journal·Rolando CimazBernhard Manger
Apr 25, 2012·Orphanet Journal of Rare Diseases·Minke H de RuFrits A Wijburg
Sep 24, 2013·Orphanet Journal of Rare Diseases·Shuan-Pei LinChih-Kuang Chuang
Jul 11, 2013·Orphanet Journal of Rare Diseases·Sandra D K KingmaNaomi van Vlies
Aug 10, 2011·Journal of Pediatric Endocrinology & Metabolism : JPEM·Julien Baruteau, Hélène Ogier de Baulny
Jun 4, 2011·Genetics and Molecular Biology·Roberto GiuglianiAna Maria Martins
Feb 16, 2013·Therapeutics and Clinical Risk Management·Mohamed F Algahim, G Hossein Almassi
Nov 25, 2011·Contemporary Clinical Dentistry·Ramesh TatapudiP Suryanarayana Raju
May 5, 2012·Contemporary Clinical Dentistry·S SharmaS Sood
Aug 31, 2014·Atlas of the Oral and Maxillofacial Surgery Clinics of North America·Victor Nannini
May 14, 2014·Journal of Inherited Metabolic Disease·Carla E M Hollak, Frits A Wijburg
May 5, 2011·Journal of Inherited Metabolic Disease·María Verónica Muñoz-RojasAna Maria Martins
Aug 7, 2013·Acta neurochirurgica·Jawad ZiyadehFederico Di Rocco
Sep 30, 2014·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Fátima Roneiva Alves FonsecaMaria Teresa Botti Rodrigues dos Santos
Mar 29, 2014·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Michael BeckShari Fallet
Apr 8, 2014·Sleep & Breathing = Schlaf & Atmung·Gustavo A MoreiraSergio Tufik
Jul 23, 2013·Current Opinion in Ophthalmology·Anuradha GaneshKhalid Al-Thihli
May 31, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Dimitry A ChistiakovAlexander A Baranov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.